カテゴリ： MarketLine, スイス, 企業調査

Clariant Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Clariant Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3717
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥24,150見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥48,300見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥72,450見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Clariant Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Clariant Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Clariant Ltd (Clariant or ‘the group’) is a global specialty chemicals producer. It operates business through four reportable segments: Plastics and Coatings, Care Chemicals, Natural Resources, and Catalysis and Energy. Clariant offers additives, such as flame retardants, polymer additives and waxes; color masterbatches, white and black masterbatches; specialty chemical solutions to oil and gas industry; pigment preparations for plastics, printing, special applications, and paints and coatings; catalysts solutions for industrial chemicals, plastics and fuels; and functional minerals. The group operates in Europe, the Americas, Asia Pacific, Africa and the Middle East. It is headquartered in Muttenz, Switzerland.

Scope

- Detailed information on Clariant Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Clariant Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Clariant Ltd. including a breakdown and examination of key business segments
- Intelligence on Clariant Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Clariant Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Clariant Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Clariant Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Clariant Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Clariant Ltd.: Company Overview 9
Clariant Ltd.: Overview and Key Facts 9
Clariant Ltd.: Overview 9
Clariant Ltd.: Key Facts 9
Clariant Ltd.: Key Employees 10
Clariant Ltd.: Key Employee Biographies 11
Clariant Ltd.: Major Products and Services 15
Clariant Ltd.: Company History 16
Clariant Ltd.: Management Statement 21
Clariant Ltd.: Locations and Subsidiaries 25
Clariant Ltd.: Key Competitors 26
Clariant Ltd.: Company Analysis 27
Clariant Ltd.: Business Description 27
Clariant Ltd.: SWOT Analysis 29
Clariant Ltd.: SWOT Overview 29
Clariant Ltd.: Strengths 29
Clariant Ltd.: Weaknesses 30
Clariant Ltd.: Opportunities 30
Clariant Ltd.: Threats 31
Clariant Ltd.: Corporate Financial Deals Activity 33
Clariant Ltd.: Financial Deals Overview 33
Clariant Ltd.: Targets and Partners 34
Clariant Ltd.: Top Deals 2014 – 2018YTD* 35
Clariant Ltd.: Advisors 36
Clariant Ltd.: Top Legal Advisors 36
Clariant Ltd.: Mergers and Acquisitions 37
Clariant Ltd.: Capital Raising 38
Clariant Ltd.: Partnership 39
Clariant Ltd.: Divestments 40
Clariant Ltd.: Recent Developments 41
Clariant Ltd.: News and Events Summary 41
Clariant Ltd.: Business Expansion 44
Clariant Ltd.: Contracts 46
Clariant Ltd.: Financial Deals 47
Clariant Ltd.: Market Developments 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Clariant Ltd.: Key Facts
Table 2: Clariant Ltd.: Key Employees
Table 3: Clariant Ltd.: Locations and Subsidiaries
Table 4: Clariant Ltd.: Key Competitors
Table 5: Clariant Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Clariant Ltd.: Targets and Partners
Table 7: Clariant Ltd.: Top Deals 2014 - 2018YTD*
Table 8: Clariant Ltd.: Legal Advisor Ranking by Value (US$m)
Table 9: Clariant Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Clariant Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Clariant Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Clariant Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Clariant Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Clariant Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Clariant Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: Clariant Ltd.: Divestments by Geography (2014 - YTD*2018)
Table 17: Clariant Ltd.: News and Events Summary
Table 18: Clariant Ltd.: Business Expansion
Table 19: Clariant Ltd.: Contracts
Table 20: Clariant Ltd.: Financial Deals
Table 21: Clariant Ltd.: Market Developments

List of Figures
Figure 1: Clariant Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Clariant Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Clariant Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Clariant Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: Clariant Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 6: Clariant Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Clariant Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Clariant Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Clariant Ltd.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Clariant Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Hensel Phelps Construction Co.：企業の戦略・SWOT・財務情報
    Hensel Phelps Construction Co. - Strategy, SWOT and Corporate Finance Report Summary Hensel Phelps Construction Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Titan Petrochemicals Group Limited (1192)：石油・ガス：M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Lyft Inc (LYFT)：企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Asterand Bioscience Inc-製薬・医療分野：企業M&A・提携分析
    Summary Asterand Bioscience Inc (Asterand) is a biopharmaceutical company that offers tissue based products and contract research services. The company offers human tissue and human tissue-based research solutions to drug discovery scientists. Its products include biospecimens, human tissue and biof …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野：企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Caltex Australia Ltd (CTX)：石油・ガス：M&Aディール及び事業提携情報
    Summary Caltex Australia Ltd (Caltex) is a supplier of transport fuels and convenience retailer. The company purchases, refines, distributes and markets petroleum products. It supplies liquefied petroleum gas (LPG), petrol, diesel, jet fuel, lubricants, greases, fuel oil and specialty products. The …
  • Repros Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Synchrony Financial：企業の戦略・SWOT・財務分析
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cable & Wireless Communications Ltd：企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • E.ON SE (EOAN)-エネルギー分野：企業M&A・提携分析
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports, and supplies gas and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • ArmaGen Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary ArmaGen Inc (ArmaGen), formerly ArmaGen Technologies Inc is a clinical stage biotechnology company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include AGT-181, AGT-182, AGT-183, AGT-184, AGT-187, AGT-115, AGT-190, AGT-110 and AGT …
  • ELITechGroup Inc：医療機器：M&Aディール及び事業提携情報
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • Microchip Technology Incorporated：企業の戦略・SWOT・財務情報
    Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report Summary Microchip Technology Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Probiodrug AG (PBD)：企業の財務・戦略的SWOT分析
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • B.P. Marsh & Partners plc (BPM)：企業の財務・戦略的SWOT分析
    Summary B.P. Marsh & Partners plc (B.P. Marsh) is a financial service provider that offers venture capital and private equity investments. The company invests in early stage financial services intermediary businesses, including insurance intermediaries, financial advisors, wealth and fund managers a …
  • AroCell AB (AROC)：製薬・医療：M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …
  • InVitae Corp (NVTA)：医療機器：M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • KCOM Group PLC (KCOM)：企業の財務・戦略的SWOT分析
    Summary KCOM Group PLC (KCOM) is a technology company that provides communication and information technology services. The company provides IT and integration services, including cloud-based infrastructure and contact and collaboration solutions. It offers broadband and telephony services for consum …
  • Zumtobel Group AG (ZAG)：企業の財務・戦略的SWOT分析
    Zumtobel Group AG (ZAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Buffalo Rock Company：企業の戦略・SWOT・財務情報
    Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report Summary Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆